Search

Friedrich Fahnert

Examiner (ID: 7481, Phone: (571)270-7797 , Office: P/2654 )

Most Active Art Unit
2654
Art Unit(s)
2614, 2692, 2654, 2651
Total Applications
770
Issued Applications
644
Pending Applications
40
Abandoned Applications
106

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 14929895 [patent_doc_number] => 20190300585 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-10-03 [patent_title] => DENDRITIC-CELL-TARGETED PEPTIDE, FUSION PEPTIDE UTILIZING SAID PEPTIDE, AND VACCINE UTILIZING SAID FUSION PEPTIDE [patent_app_type] => utility [patent_app_number] => 16/335625 [patent_app_country] => US [patent_app_date] => 2017-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10535 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16335625 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/335625
Dendritic-cell-targeted peptide, fusion peptide utilizing said peptide, and vaccine utilizing said fusion peptide Sep 20, 2017 Issued
Array ( [id] => 12624504 [patent_doc_number] => 20180099998 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-04-12 [patent_title] => STAPHYLOCOCCUS AUREUS LEUKOCIDINS, THERAPEUTIC COMPOSITIONS, AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 15/699482 [patent_app_country] => US [patent_app_date] => 2017-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14672 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15699482 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/699482
None Sep 7, 2017 Issued
Array ( [id] => 17741449 [patent_doc_number] => 11389494 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-07-19 [patent_title] => Composition for suppressing or improving eye fatigue [patent_app_type] => utility [patent_app_number] => 16/331849 [patent_app_country] => US [patent_app_date] => 2017-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 14598 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16331849 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/331849
Composition for suppressing or improving eye fatigue Sep 7, 2017 Issued
Array ( [id] => 15239687 [patent_doc_number] => 20190374629 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-12-12 [patent_title] => THERMOSTABLE VARIANTS OF P. FALCIPARUM PFRH5 WHICH CAN BE PRODUCED IN BACTERIAL CELLS [patent_app_type] => utility [patent_app_number] => 16/331863 [patent_app_country] => US [patent_app_date] => 2017-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31827 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16331863 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/331863
THERMOSTABLE VARIANTS OF P. FALCIPARUM PFRH5 WHICH CAN BE PRODUCED IN BACTERIAL CELLS Sep 6, 2017 Pending
Array ( [id] => 19519851 [patent_doc_number] => 12121549 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-10-22 [patent_title] => Application of [patent_app_type] => utility [patent_app_number] => 16/642741 [patent_app_country] => US [patent_app_date] => 2017-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8823 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16642741 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/642741
Application of Aug 28, 2017 Issued
Array ( [id] => 17185227 [patent_doc_number] => 20210332112 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-10-28 [patent_title] => STABILIZED PERTUSSIS ANTIBODIES WITH EXTENDED HALF-LIFE [patent_app_type] => utility [patent_app_number] => 16/325710 [patent_app_country] => US [patent_app_date] => 2017-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19390 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -43 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16325710 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/325710
STABILIZED PERTUSSIS ANTIBODIES WITH EXTENDED HALF-LIFE Aug 14, 2017 Abandoned
Array ( [id] => 14375243 [patent_doc_number] => 20190161534 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-05-30 [patent_title] => ANTI-GALACTAN II MONOCLONAL ANTIBODIES TARGETING KLEBSIELLA PNEUMONIAE [patent_app_type] => utility [patent_app_number] => 16/321528 [patent_app_country] => US [patent_app_date] => 2017-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21160 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16321528 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/321528
ANTI-GALACTAN II MONOCLONAL ANTIBODIES TARGETING KLEBSIELLA PNEUMONIAE Aug 10, 2017 Abandoned
Array ( [id] => 13699803 [patent_doc_number] => 20170360856 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-12-21 [patent_title] => COMPOSITIONS COMPRISING BACTERIAL STRAINS [patent_app_type] => utility [patent_app_number] => 15/673270 [patent_app_country] => US [patent_app_date] => 2017-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22818 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15673270 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/673270
Compositions comprising bacterial strains Aug 8, 2017 Issued
Array ( [id] => 13699803 [patent_doc_number] => 20170360856 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-12-21 [patent_title] => COMPOSITIONS COMPRISING BACTERIAL STRAINS [patent_app_type] => utility [patent_app_number] => 15/673270 [patent_app_country] => US [patent_app_date] => 2017-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22818 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15673270 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/673270
Compositions comprising bacterial strains Aug 8, 2017 Issued
Array ( [id] => 13699803 [patent_doc_number] => 20170360856 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-12-21 [patent_title] => COMPOSITIONS COMPRISING BACTERIAL STRAINS [patent_app_type] => utility [patent_app_number] => 15/673270 [patent_app_country] => US [patent_app_date] => 2017-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22818 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15673270 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/673270
Compositions comprising bacterial strains Aug 8, 2017 Issued
Array ( [id] => 13699803 [patent_doc_number] => 20170360856 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-12-21 [patent_title] => COMPOSITIONS COMPRISING BACTERIAL STRAINS [patent_app_type] => utility [patent_app_number] => 15/673270 [patent_app_country] => US [patent_app_date] => 2017-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22818 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15673270 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/673270
Compositions comprising bacterial strains Aug 8, 2017 Issued
Array ( [id] => 16862802 [patent_doc_number] => 11021534 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-06-01 [patent_title] => Mycobacterial antigen composition [patent_app_type] => utility [patent_app_number] => 15/672085 [patent_app_country] => US [patent_app_date] => 2017-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 28697 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 98 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15672085 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/672085
Mycobacterial antigen composition Aug 7, 2017 Issued
Array ( [id] => 17392501 [patent_doc_number] => 11241489 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-02-08 [patent_title] => Multivalent pneumococcal polysaccharide-protein conjugate composition [patent_app_type] => utility [patent_app_number] => 16/322726 [patent_app_country] => US [patent_app_date] => 2017-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 16115 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 119 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16322726 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/322726
Multivalent pneumococcal polysaccharide-protein conjugate composition Aug 3, 2017 Issued
Array ( [id] => 14980619 [patent_doc_number] => 10444217 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2019-10-15 [patent_title] => Rapid analysis for cyanobacterial toxins [patent_app_type] => utility [patent_app_number] => 15/667822 [patent_app_country] => US [patent_app_date] => 2017-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 11941 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15667822 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/667822
Rapid analysis for cyanobacterial toxins Aug 2, 2017 Issued
Array ( [id] => 12049878 [patent_doc_number] => 20170326223 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-11-16 [patent_title] => 'NOVEL SURFACE EXPOSED HAEMOPHILUS INFLUENZAE PROTEIN (PROTEIN E; pE)' [patent_app_type] => utility [patent_app_number] => 15/660455 [patent_app_country] => US [patent_app_date] => 2017-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 25893 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15660455 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/660455
Surface exposed Jul 25, 2017 Issued
Array ( [id] => 14715555 [patent_doc_number] => 20190248841 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-08-15 [patent_title] => Immunogenic Composition [patent_app_type] => utility [patent_app_number] => 16/308972 [patent_app_country] => US [patent_app_date] => 2017-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37703 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16308972 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/308972
Immunogenic Composition Jun 14, 2017 Abandoned
Array ( [id] => 14621467 [patent_doc_number] => 20190224101 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-07-25 [patent_title] => HUMAN ANTIBODY SPECIFICALLY BINDING TO ACNE BACTERIA USING PHAGE DISPLAY TECHNIQUE, AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 16/309582 [patent_app_country] => US [patent_app_date] => 2017-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7993 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16309582 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/309582
Human antibody specifically binding to acne bacteria using phage display technique, and use thereof Jun 12, 2017 Issued
Array ( [id] => 16360987 [patent_doc_number] => 20200317738 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-10-08 [patent_title] => METHODS FOR INCREASING PROLIFERATION OF MAMMALIAN CELLS [patent_app_type] => utility [patent_app_number] => 16/303483 [patent_app_country] => US [patent_app_date] => 2017-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11709 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -46 [patent_words_short_claim] => 4 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16303483 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/303483
METHODS FOR INCREASING PROLIFERATION OF MAMMALIAN CELLS May 25, 2017 Abandoned
Array ( [id] => 15898421 [patent_doc_number] => 20200148729 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-05-14 [patent_title] => Compositions and Methods for Treating Secondary Tuberculosis and Nontuberculosis Mycobacterium Infections [patent_app_type] => utility [patent_app_number] => 16/098911 [patent_app_country] => US [patent_app_date] => 2017-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24826 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16098911 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/098911
Compositions and Methods for Treating Secondary Tuberculosis and Nontuberculosis Mycobacterium Infections May 18, 2017 Abandoned
Array ( [id] => 15145115 [patent_doc_number] => 20190351035 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-11-21 [patent_title] => VACCINE AGAINST TRYPANOSOMA CRUZI INFECTION [patent_app_type] => utility [patent_app_number] => 16/311597 [patent_app_country] => US [patent_app_date] => 2017-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4446 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -3 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16311597 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/311597
VACCINE AGAINST TRYPANOSOMA CRUZI INFECTION May 1, 2017 Abandoned
Menu